1 |
Han CH, Lu J, Wei Q, et al (2010). The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger. Breast Cancer Res Treat, 122, 243-9.
DOI
|
2 |
He J, Zhou F, Shao K, et al (2007). Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases. Lung Cancer, 56, 51-8.
DOI
ScienceOn
|
3 |
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
DOI
ScienceOn
|
4 |
Lu J, Yang L, Zhao H, et al (2011). The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in Southern and Eastern Chinese populations. Hum Mutat, 32, 1299-308.
DOI
ScienceOn
|
5 |
Lu KP, Zhou XZ (2007). The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol, 8, 904-16.
DOI
ScienceOn
|
6 |
Lu Y, Huang GL, Pu XX, et al (2013). Association between PIN1 promoter polymorphisms and risk of nasopharyngeal carcinoma. Mol Biol Rep, 40, 3777-82.
DOI
ScienceOn
|
7 |
Miyashita H, Mori S, Motegi K, et al (2003). Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol Rep, 10, 455-61.
|
8 |
Ramsberg J, Asseburg C, Henriksson M (2012). Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model. PLoS One, 7, e42003.
DOI
|
9 |
Molina JD, Lopez-Munoz F, Stein DJ, et al (2009). Borderline personality disorder: a review and reformulation from evolutionary theory. Med Hypotheses, 73, 382-6.
DOI
ScienceOn
|
10 |
Naidu R, Har YC, Taib NA (2011). Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G > C) and -667(T> C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters. Scand J Clin Lab Invest, 71, 500-6.
DOI
ScienceOn
|
11 |
Perez-Losada J, Castellanos-Martin A, Mao JH (2011). Cancer evolution and individual susceptibility. Integr Biol (Camb), 3, 316-28.
DOI
ScienceOn
|
12 |
Segat L, Milanese M, Crovella S (2007). Pin1 promoter polymorphisms in hepatocellular carcinoma patients. Gastroenterology, 132, 2618-9; author reply 9-20.
DOI
ScienceOn
|
13 |
Theuerkorn M, Fischer G, Schiene-Fischer C (2011). Prolyl cis/trans isomerase signalling pathways in cancer. Curr Opin Pharmacol, 11, 281-7.
DOI
ScienceOn
|
14 |
Xue H, Lin B, Ni P, et al (2010). Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol, 25, 1604-17.
DOI
ScienceOn
|
15 |
You Y, Deng J, Zheng J, et al (2013). Functional polymorphisms in PIN1 promoter and esophageal carcinoma susceptibility in Chinese population. Mol Biol Rep, 40, 829-38.
DOI
ScienceOn
|
16 |
Zhao H (2009). Association between polymorphisms in prolyl isomerase Pin1 promoter and risk for lung cancer. . Guangzhou Medical University: [D] Guangzhou.
|
17 |
Chung CC, Chanock SJ (2011). Current status of genome-wide association studies in cancer. Hum Genet, 130, 59-78.
DOI
|
18 |
Carpenter RW, Tomko RL, Trull TJ, Boomsma DI. (2013). Gene-environment studies and borderline personality disorder: a review. Curr Psychiatry Rep, 15, 336.
DOI
|
19 |
Ayala G, Wang D, Wulf G, et al (2003). The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res, 63, 6244-51.
|
20 |
Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
DOI
ScienceOn
|
21 |
DeYoung CG, Clark R (2012). The gene in its natural habitat: the importance of gene-trait interactions. Dev Psychopathol, 24, 1307-18.
DOI
ScienceOn
|
22 |
Dick, DM (2011). Gene-environment interaction in psychological traits and disorders. Annu Rev Clin Psychol, 7, 383-409.
DOI
ScienceOn
|
23 |
Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
DOI
ScienceOn
|
24 |
Euhus DM, Robinson L (2013). Genetic predisposition syndromes and their management. Surg Clin North Am, 93, 341-62.
DOI
ScienceOn
|
25 |
Fukuchi M, Fukai Y, Kimura H, et al (2006). Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Int J Oncol, 29, 329-34.
|
26 |
Gao LB, Pan XM, Sun H, et al (2010). The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis. J Exp Clin Cancer Res, 29, 117.
DOI
ScienceOn
|
27 |
Liou YC, Zhou XZ, Lu KP (2011). Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem Sci, 36, 501-14.
DOI
ScienceOn
|
28 |
Lu J, Hu Z, Wei S, et al (2009). A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. Carcinogenesis, 30, 1717-21.
DOI
ScienceOn
|
29 |
Cao WP, Tang HL, Lin P (2012). Association between polymorphisms in prolyl isomerase Pin1 and risk for laryngeal squamous cell carcinoma. Jiangsu Med, 38, 1067-670.
|